SenoRx was founded in 1998 to design, develop, manufacture and market minimally invasive devices for the diagnosis and treatment of breast cancer. We place a high priority on outstanding customer service and on maintaining and growing a strong portfolio of intellectual property. Our goal is to become the leader in our industry by offering products and procedures that dramatically enhance patient outcomes.